Interventional Neurology Market Research Report – Global Forecast till 2027

Interventional Neurology Market Research Report: By Disease Pathology (Cerebral Aneurysms, Ischemic Strokes, & Others), Product (Aneurysm Coiling & Embolization, Neurothrombectomy, Support Devices, & Others), End User – Global Forecast Till 2027

ID: MRFR/HC/5745-HCR | February 2021 | Region: Global | 90 pages

Market Scenario


Global interventional neurology market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 1832.6 million in 2017 and is projected to grow at a CAGR of 7.8% over the forecast period.


Interventional neurology refers to endovascular, catheter-based technique used to diagnose and treat vascular disease of the central nervous system.


Rising prevalence of neurological diseases is one of the key factors driving the interventional neurology market. Out of 1.2 million most frequently diagnosed adult-onset brain disorders, 21% and 51.3% are due to Alzheimer’s disease and stroke, respectively.


Various other factors such as technological advancements, presence of a large target patient population, favourable medical reimbursements and growing demand for effective neurovascular devices are also expected to propel the growth of the market.


However, lack of skilled neurosurgeons and stringent regulations can hamper the market growth over the forecast period.


Segmentation


The global interventional neurology market is segmented based on disease pathology, product, end user and region.


The global market for interventional neurology, by disease pathology is segmented into cerebral aneurysms, arteriovenous malformation and fistulas, ischemic strokes, and others.


The market, by product, is segmented into aneurysm coiling & embolization devices, cerebral balloon angioplasty and stenting systems, neurothrombectomy devices, and support devices. The aneurysm coiling & embolization devices segment is further classified as embolic coils, flow diversion devices, and liquid embolic agents. The embolic coils segment includes bare detachable coils, and coated detachable coils. The cerebral balloon angioplasty and stenting systems segment is further classified as carotid artery stents, and embolic protection systems. The embolic protection systems segment includes distal filter devices, and balloon occlusion devices. The neurothrombectomy devices are further classified as clot retrieval devices, suction and aspiration devices, and snares. The support devices are further classified as microcatheters, and microguidewires.


Based on end user, the market is segmented into hospitals & clinics, ambulatory surgical centres, research & academic institutes, and others.


In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region.


The interventional neurology market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European interventional neurology market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The interventional neurology market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The interventional neurology market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Interventional Neurology market Share (%), by Region, 2017


Interventional Neurology market


Sources: MRFR Analysis


The Americas dominated the global market for interventional neurology owing to presence of major market players and rising geriatric population.


In 2017, it was estimated that Europe stood second in the global interventional neurology market. This can be attributed to the rising research and development investments.


The rising participation of market players is also boosting the interventional neurology market. For instance, in 2018, Rapid Medical announced CE Mark approval in the European Union for its Tigertriever 13 stent retriever for the treatment of ischemic stroke.


Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing healthcare expenditure drives the regional markets of the Asia Pacific region. According to the 2017 data suggested by the Australian Institute of Health and Welfare, nearly USD 181 billion is spent on health in Australia.


On the other hand, the Middle East and Africa held least share in the global interventional neurology market due to the low per capita income, especially within the African region. The growth in this region is attributed to the rising cases neurological conditions. The burden of neurological disorders in African region has been increasing over the years. The annual incidence of stroke has been estimated to be 316 per 100 000 in Africa.


Key players


Some of the key players in the global interventional neurology market are Abbott Laboratories, Johnson & Johnson, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC, Terumo Corporation, Penumbra, Inc., Microport Scientific Corporation, Merit Medical Systems, Inc., W.L. Gore & Associates, Inc., B. Braun Melsungen AG, Cook Medical, and others.


Research Methodology


Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.



  • Primary Research


Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.



  • Secondary Research


Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the Interventional Neurology. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.


 Intended Audience



  • Medical Device Companies

  • Government and Private Laboratories

  • Research and Development (R&D) companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers


Market Segmentation and Key Market Players


Global Interventional Neurology Market, by Disease Pathology



  • Cerebral Aneurysms

  • Arteriovenous Malformation and Fistulas

  • Ischemic Strokes

  • Others


Global Interventional Neurology Market, by Product



  • Aneurysm Coiling & Embolization Devices


    • Embolic Coils


      • Bare Detachable Coils

      • Coated Detachable Coils


    • Flow Diversion Devices

    • Liquid Embolic Agents


  • Cerebral Balloon Angioplasty and Stenting Systems


    • Carotid Artery Stents

    • Embolic Protection Systems


      • Distal Filter Devices

      • Balloon Occlusion Devices



  • Neurothrombectomy Devices


    • Clot Retrieval Devices

    • Suction and Aspiration Devices

    • Snares


  • Support Devices


    • Microcatheters

    • Microguidewires



Global Interventional Neurology Market, by End User



  • Hospitals & Clinics

  • Ambulatory Surgical Centers

  • Research & Academic Institutes 

  • Others



Frequently Asked Questions (FAQ) :


The global interventional neurology market had reached a valuation of USD 1832.6 MN in 2017.

The global interventional neurology market is projected to grow at approximately 7.8% CAGR during forecast period (2018-2023).

North America holds the largest share in the global interventional neurology market followed by Europe and Asia Pacific, respectively.

Johnson & Johnson, Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, Stryker Corporation, Terumo Corporation, Microport Scientific Corporation, Penumbra, Inc., Merit Medical Systems, Inc., B. Braun Melsungen AG, W.L. Gore & Associates, Inc., and Cook Medical, are some of the major players operating in the interventional neurology market.

Table of Contents:


Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Interventional Neurology Market, by Disease Pathology

6.1 Introduction

6.2 Cerebral Aneurysms

Market Estimates &Forecast, by Region, 2020-2027

Market Estimates &Forecast, by Country, 2020-2027

6.3 Arteriovenous Malformation and Fistulas

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Ischemic Strokes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Interventional Neurology Market, by Product

7.1 Introduction

7.2 Aneurysm Coiling & Embolization Devices

7.2.1 Embolic Coils

7.2.1.1 Bare Detachable Coils

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.1.2 Coated Detachable Coils

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.2 Flow Diversion Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.3 Liquid Embolic Agents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Cerebral Balloon Angioplasty and Stenting Systems

7.3.1 Carotid Artery Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3.2 Embolic Protection Systems

7.3.2.1 Distal Filter Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3.2.2 Balloon Occlusion Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Neurothrombectomy Devices

7.4.1 Clot Retrieval Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4.2 Suction and Aspiration Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4.3 Snares

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Support Devices

7.5.1 Microcatheters

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5.2 Microguidewires

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Interventional Neurology Market, by End User

8.1 Introduction

8.2 Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Research & Academic Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Interventional Neurology Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Abbott Laboratories

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Medtronic PLC

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Johnson & Johnson

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Boston Scientific Corporation

11.4.1 Company Overview

11.4.2 Technologys/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Stryker Corporation

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Terumo Corporation

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Penumbra, Inc.

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Microport Scientific Corporation

11.8.1 Overview

11.8.2 Type/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Merit Medical Systems, Inc.

11.9.1 Overview

11.9.2 TypeOverview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 W.L. Gore & Associates, Inc.

11.10.1 Overview

11.10.2 TypeOverview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 B. Braun Melsungen AG

11.11.1 Overview

11.11.2 TypeOverview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Cook Medical

11.12.1 Overview

11.12.2 Type Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Other

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictionsfor the Global Interventional Neurology Market

Chapter 13. Appendix

LIST OF TABLES

Table 1 Interventional Neurology Market Synopsis, 2020-2027

Table 2 Interventional Neurology Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Interventional Neurology Market, by Region, 2020-2027 (USD Million)

Table 4 Global Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 5 Global Interventional Neurology Market, by Product, 2020-2027 (USD Million)

Table 6 Global Interventional Neurology Market, End User, 2020-2027 (USD Million)

Table 7 North America: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 8 North America: Interventional Neurology Market, by Product, 2020-2027(USD Million)

Table 9 North America: Interventional Neurology Market, End User, 2020-2027 (USDMillion)

Table 10 US: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 11 US: Interventional Neurology Market, by Product, 2020-2027 (USD Million)

Table 12 US: Interventional Neurology Market, End User, 2020-2027 (USD Million)

Table 13 Canada:Interventional Neurology Market,byTechnique, 2020-2027 (USD Million)

Table 14 Canada: Interventional Neurology Market, by Product, 2020-2027 (USD Million)

Table 15 Canada: Interventional Neurology Market, End User, 2020-2027 (USDMillion)

Table 16 South America: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 17 South America: Interventional Neurology Market, by Product, 2020-2027 (USD Million)

Table 18 South America: Interventional Neurology Market, End User, 2020-2027 (USDMillion)

Table 19 Europe: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 20 Europe: Interventional Neurology Market, by Product, 2020-2027 (USD Million)

Table 21 Europe: Interventional Neurology Market, End User, 2020-2027 (USD Million)

Table 22 Western Europe: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USDMillion)

Table 23 Western Europe: Interventional Neurology Market, by Product, 2020-2027 (USD Million)

Table 24 Western Europe: Interventional Neurology Market, by End User, 2020-2027(USD Million)

Table 25 Eastern Europe: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 26 Eastern Europe: Interventional Neurology Market, by Product, 2020-2027 (USD Million)

Table 27 Eastern Europe: Interventional Neurology Market, End User, 2020-2027(USD Million)

Table 28 Asia-Pacific: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 29 Asia-Pacific: Interventional Neurology Market,by Product, 2020-2027 (USD Million)

Table 30 Asia-Pacific: Interventional Neurology Market, End User, 2020-2027 (USD Million)

Table 31 Middle East & Africa: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 32 Middle East & Africa: Interventional Neurology Market, by Product,2020-2027 (USD Million)

Table 33 Middle East & Africa: Interventional Neurology Market, End User, 2020-2027(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Interventional Neurology Market

Figure 3 Market Dynamics for Global Interventional Neurology Market

Figure 4 Interventional Neurology Market Share, by Disease Pathology,2020

Figure 5 Interventional Neurology Market Share, by Product,2020

Figure 6 Interventional Neurology Market Share, End User, 2020

Figure 7 Interventional Neurology Market Share, by Region, 2020

Figure 8 North America: Interventional Neurology Market Share, by Country, 2020

Figure 9 Europe: Interventional Neurology Market Share, by Country, 2020

Figure 10 Asia-Pacific: Interventional Neurology Market Share, by Country, 2020

Figure 11 Middle East & Africa: Interventional Neurology Market Share, by Region, 2020

Figure 12 Interventional Neurology Market : Company Share Analysis, 2020 (%)

Figure 13 Abbott Laboratories: Key Financials

Figure 14 Abbott Laboratories: Segmental Revenue

Figure 15 Abbott Laboratories: Geographical Revenue

Figure 16 Medtronic PLC : Key Financials

Figure 17 Medtronic PLC : Segmental Revenue

Figure 18 Medtronic PLC : Geographical Revenue

Figure 19 Johnson & Johnson:Key Financials

Figure 20 Johnson & Johnson: Segmental Revenue

Figure 21 Johnson & Johnson: Geographical Revenue

Figure 22 Boston Scientific Corporation: Key Financials

Figure 23 Boston Scientific Corporation: Segmental Revenue

Figure 24 Boston Scientific Corporation: Geographical Revenue

Figure 25 Stryker Corporation:Key Financials

Figure 26 Stryker Corporation: Segmental Revenue

Figure 27 Stryker Corporation: Geographical Revenue

Figure 28 Terumo Corporation: Key Financials

Figure 29 Terumo Corporation: Segmental Revenue

Figure 30 Terumo Corporation: Geographical Revenue

Figure 31 Penumbra, Inc.: Key Financials

Figure 32 Penumbra, Inc.: Segmental Revenue

Figure 33 Penumbra, Inc.: Geographical Revenue

Figure 34 Microport Scientific Corporation:Key Financials

Figure 35 Microport Scientific Corporation: Segmental Revenue

Figure 36 Microport Scientific Corporation: Geographical Revenue

Figure 37 Merit Medical Systems, Inc.: Key Financials

Figure 38 Merit Medical Systems, Inc.: Segmental Revenue

Figure 39 Merit Medical Systems, Inc.: Geographical Revenue

Figure 40 W.L. Gore & Associates, Inc.: Key Financials

Figure 41 W.L. Gore & Associates, Inc.: Segmental Revenue

Figure 42 W.L. Gore & Associates, Inc.: Geographical Revenue

Figure 43 B. Braun Melsungen AG : Key Financials

Figure 44 B. Braun Melsungen AG :Segmental Revenue

Figure 45 B. Braun Melsungen AG : Geographical Revenue

Figure 46 Cook Medical: Key Financials

Figure 47 Cook Medical: Segmental Revenue

Figure 48 Cook Medical: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.